Related Experiment Video
Updated: Jun 5, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Structure-metabolism relationships for the glucuronidation of flavonoids by UGT1A3 and UGT1A9
Shenggu Xie1, Yakun Chen, Shuqing Chen
1Department of Pharmaceutical Analysis and Drug Metabolism, College of Pharmaceutical Sciences, Zhejiang University Zhejiang Institute of Food and Drug Control, Hangzhou, Zhejiang, China.
Objectives:
This study tries to find structure-metabolism relationships between flavonoids and human UGT1A3 and UGT1A9.
Methods:
The glucuronidation of flavonoids was studied with recombinant UGT1A3 and UGT1A9, and the glucuronidation activity was determined by HPLC.
Key Findings:
Of the flavonoids studied, it was shown for the first time that baicalein, quercetin-3-OCH(2) OCH(3) , quercetin-4'-CH(3) , quercetin-3'-OCH(3) and quercetin-3'-Br are substrates of UGT1A3. Wogonin, baicalein, quercetin-4'-Cl, quercetin-3-OCH(2) OCH(3) , quercetin-3-O-arabinoside, quercetin-4'-CH(3) , quercetin-3'-OCH(3) and quercetin-3'-Br are the newly reported substrates of UGT1A9. The preferred substrates for UGT1A3 and UGT1A9 contain the hydroxyl group at the C7-position. The glycon and the position of the B ring have conspicuous influences on the glucuronidation activity, and other chemical structures of flavonoids have minor effects.
Conclusions:
From the quantitative study, UGT1A9 in general has higher glucuronidation efficiency than UGT1A3.
More Related Videos
Related Concept Videos
Phase II Reactions: Glucuronidation
Drug Metabolism: Phase II Reactions
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Drug Metabolism: Phase I Reactions

